Dhampur Bio's ₹37 Cr Q1 profit is all a one-off asset-sale gain; core ops stay loss-making

Dhampur Bio Organics reported a consolidated net profit of ₹36.79 Cr for Q1 FY27 (EPS ₹5.59), reversing a ₹22.00 Cr loss in the year-ago quarter. The reversal is not operational: it rests entirely on a ₹63.89 Cr gain from the slump-sale of the Meerganj (Bareilly) sugar and co-generation unit for ₹305 Cr, transferred June 18, 2026 and classified under discontinued operations. Strip that one-off out and the group would have posted a net loss of roughly ₹27 Cr — wider than last year's ₹22 Cr loss (~-23% adjusted). Continuing operations alone lost ₹13.75 Cr after tax on a ₹18.29 Cr pre-tax loss, only marginally better than the ₹20.88 Cr pre-tax loss a year ago. Continuing-operations revenue rose ~22% YoY to ₹918.56 Cr (₹750.64 Cr) and ~33% sequentially, but this is a seasonal print — management explicitly flags that a single sugar quarter is not representative of the year. The mix shifted sharply: Country Liquor nearly doubled to ₹489.08 Cr and is now the largest segment, while Sugar (₹371.32 Cr) and Bio Fuels & Spirits (₹80.78 Cr) both shrank YoY. Profitability is the problem — total segment results were just ₹12.54 Cr (1.4% of revenue), and finance costs of ₹15.56 Cr alone more than wiped that out, keeping the core business in the red despite higher sales; net margin excluding the one-off is negative. Alongside the result, the board acquired a 74% stake in DBION Pvt Ltd (July 9), reappointed Grant Thornton Bharat as internal auditor and declared no interim dividend; the numbers are unaudited (limited review, unmodified conclusion). The company gives no formal guidance and there is no brokerage consensus on record for a stock of this size, so there is no street or guidance benchmark to measure against. Net read: the headline profit is a portfolio-restructuring event — exiting a sugar unit — not a turn in the underlying business, which stayed loss-making even as revenue grew.